Home zacks
 

Keywords :   


Tag: zacks

Zacks Investment Research Downgrades Cal-Maine Foods Inc (CALM) to Hold

2015-12-29 07:29:08| Food - Topix.net

According to Zacks, "Cal-Maine Foods, Inc. is engaged in the production, cleaning, grading, and packaging of fresh shell eggs for sale to shell egg retailers. The company is the one of the largest producers and distributors of fresh shell eggs in the United States.

Tags: research hold investment foods

 

Zacks Investment Research Downgrades Cal-Maine Foods Inc (CALM) to Hold

2015-12-29 06:52:34| Livestock - Topix.net

According to Zacks, "Cal-Maine Foods, Inc. is engaged in the production, cleaning, grading, and packaging of fresh shell eggs for sale to shell egg retailers. The company is the one of the largest producers and distributors of fresh shell eggs in the United States.

Tags: research hold investment foods

 
 

Papa Murphy's Holdings Inc (FRSH) Upgraded to "Hold" by Zacks Investment Research

2015-12-29 06:15:25| Grocery - Topix.net

According to Zacks, "Papa Murphy's Holdings Inc. operates as a franchisor and operator of the Take 'N' Bake pizza chain in the United States. The Company operates in three segments: Domestic Company Stores, Domestic Franchise and International.

Tags: research hold investment holdings

 

Zacks Investment Research Lowers Discovery Laboratories, Inc. (DSCO) to Sell

2015-12-29 06:13:10| Biotech - Topix.net

According to Zacks, "Discovery Laboratories, Inc., formerly known as Ansan Pharmaceuticals, Inc., is a development-stage pharmaceutical company that focuses on developing compounds to treat respiratory diseases that affect the ability of the lungs to absorb oxygen. It is initially developing its lead product candidate, Surfaxin, for use by newborn infants to treat two respiratory conditions in critical care units of hospitals.

Tags: research sell investment discovery

 

CTI BioPharma Corp (CTIC) Upgraded at Zacks Investment Research

2015-12-29 06:13:09| Biotech - Topix.net

The brokerage currently has a $1.50 price objective on the biopharmaceutical company's stock. Zacks Investment Research 's price target would indicate a potential upside of 16.28% from the stock's current price.

Tags: research investment corp upgraded

 

Sites : [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] next »